Samiksha Nayak

TL;DR: It is demonstrated that a full laboratory-quality immunoassay can be run on a smartphone accessory, and suggests that coupling microfluidics with recent advances in consumer electronics can make certain laboratory-based diagnostics accessible to almost any population with access to smartphones.

TL;DR: This paper presents a meta-modelling framework for estimating the modeled response of the immune system to various types of injury and shows clear patterns of decline in response to certain types of injuries.

TL;DR: The use of microfluidics technology to develop a multiplexed rapid lab-on-a-chip point of care (POC) assay for the serologic diagnosis of human Lyme disease shows promising performance for detection of antibodies to B. burgdorferi using the PPO triplex test.

TL;DR: In this article, the authors describe user preferences for a smartphone app to mitigate these challenges and how these were integrated into the SMARTtest app to support self- and partner-testing using the INSTI Multiplex®.

TL;DR: The mChip-Ld platform outperformed the STT algorithm according to sensitivity and opens the door for the development of a single, rapid, multiplexed diagnostic test for point-of-care use that can be designed to identify the Lyme disease stage.